Ainostrum is a technology company at the forefront of applying artificial intelligence (AI) and machine learning (ML) to transform the life sciences and healthcare industries. They specialize in developing advanced computational platforms to accelerate drug discovery, optimize preclinical and clinical research, enhance diagnostic capabilities, and enable personalized medicine. By analyzing complex biological and clinical data, Ainostrum aims to provide actionable insights that empower pharmaceutical companies, biotech firms, and research institutions to bring novel therapies to patients faster and more efficiently. Their core mission is to reduce the time and cost associated with R&D, ultimately improving patient outcomes.
Serves as the company's primary center for strategic leadership, research and development in AI, business development, and corporate operations. Its Palo Alto location facilitates access to top-tier talent, collaborations with academic institutions, and engagement with the tech and biotech communities.
Likely housed in a modern office building or tech park characteristic of Silicon Valley, featuring collaborative workspaces and advanced IT infrastructure to support intensive AI research and computational biology tasks.
A dynamic, innovative, and intellectually driven environment typical of a tech startup in the life sciences sector. The culture likely emphasizes collaboration, scientific rigor, agility, and a strong sense of purpose in tackling complex healthcare challenges.
The Palo Alto headquarters is significant for its proximity to world-class research institutions like Stanford University, a rich talent pool in AI and biotech, and a dense network of investors and industry partners, all crucial for Ainostrum's growth and innovation.
Ainostrum operates with a global mindset, maintaining a key presence in the United States (Palo Alto, CA) and India (Bangalore). This strategic distribution of its team allows for continuous R&D cycles, access to diverse global talent, and the ability to serve and collaborate with international partners in the pharmaceutical, biotech, and academic sectors. Their functions supported globally include AI research, platform development, data analysis, and business development.
3000 El Camino Real, Bldg 4, Suite 200
Palo Alto
CA
USA
Address: No. 365, EPIP Industrial Area, Whitefield, Bangalore, Karnataka, India, 560066
To access specialized tech talent for advanced R&D, scale software development capabilities cost-effectively, and support global projects with a diversified operational footprint.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Ainostrum' leadership includes:
Ainostrum has been backed by several prominent investors over the years, including:
Based on publicly available information, Ainostrum has not announced major C-suite executive hires or departures within the last 12 months, indicating stability in its core leadership team. Key executive team members, including the Chief Commercial Officer and VP of Strategy & Operations, were appointed in early 2023, strengthening the company's strategic and commercial capabilities.
Discover the tools Ainostrum uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Ainostrum likely uses standard professional email formats for its correspondence. Common patterns at technology companies include using the first name and last name, or the first initial and last name, followed by the company domain.
[first].[last]@ainostrum.us or [first_initial][last]@ainostrum.us
Format
jane.doe@ainostrum.us or jdoe@ainostrum.us
Example
75%
Success rate
YourStory • February 26, 2024
Ainostrum, co-founded by Dr. Suman Chandra, Subrat Chandra, and Dr. Rajendra Shinde, is utilizing AI to significantly accelerate drug discovery and development processes. The article highlights their innovative approach, expansion plans for their teams in Bengaluru and US (Palo Alto), and their focus on areas like rare diseases and personalized medicine....more
Business Standard / PTI • November 16, 2023
Ainostrum officially launched AiDrugOpt, its proprietary AI-driven platform. This platform is designed to dramatically reduce the timelines and expenses associated with discovering and developing new drugs, aiming to boost R&D productivity for pharmaceutical and biotechnology companies....more
BioSpectrum India • November 17, 2023
This report details the launch of Ainostrum's AiDrugOpt platform, emphasizing its AI capabilities for identifying novel drug candidates, predicting their efficacy, and optimizing clinical trial designs. It underscores Ainostrum's mission to transform pharmaceutical R&D through advanced AI....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Ainostrum, are just a search away.